Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

[Analyses on the relative factors regarding diabetic nephropathy].

Shao HL, Song CQ, Xu DH, Shang XJ, Hao ZH.

Zhonghua Liu Xing Bing Xue Za Zhi. 2013 Apr;34(4):393-5. Chinese.

PMID:
23937848
2.

[Analyses on the relative factors regarding diabetic nephropathy among 1758 cases of type 2 diabetic patients].

Zhou Y, Guo LX, Yu DN, Zhou L, Wang Y, Mou ZQ, Wang XX, Zhang LN, Li M.

Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Jun;33(6):610-3. Chinese.

PMID:
22883271
3.

[Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].

Guo M, Xi G, Yang N, Yao H.

Zhonghua Gan Zang Bing Za Zhi. 2014 Aug;22(8):631-5. doi: 10.3760/cma.j.issn.1007-3418.2014.08.016. Chinese.

PMID:
25243967
5.

Urinary albumin excretion rate: a risk factor for retinal hard exudates in macular region in type 2 diabetic patients.

Wang S, Lin S, Cao X, Zheng Y, Wang J, Lu N, Yang J.

Chin Med J (Engl). 2014;127(12):2293-8.

PMID:
24931245
6.

Urinary albumin excretion rate is independently related to autonomic neuropathy in type 2 diabetes mellitus.

Wirta OR, Pasternack AI, Mustonen JT, Laippala PJ, Reinikainen PM.

J Intern Med. 1999 Apr;245(4):329-35.

7.

Non-alcoholic fatty liver disease is not related to the incidence of diabetic nephropathy in Type 2 Diabetes.

Zhan YT, Zhang C, Li L, Bi CS, Song X, Zhang ST.

Int J Mol Sci. 2012 Nov 12;13(11):14698-706. doi: 10.3390/ijms131114698.

9.

[Relations between serum adipocyte fatty acid-binding protein and type 2 diabetes in a community population].

YE WH, PENG XH, AI YQ, CHEN H, ZHANG H, CAI DH.

Nan Fang Yi Ke Da Xue Xue Bao. 2011 Mar;31(3):508-11. Chinese.

10.

Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients.

Wirta OR, Pasternack AI, Mustonen JT, Koivula TA, Harmoinen A.

Nephrol Dial Transplant. 1996 Mar;11(3):449-56.

PMID:
8671814
11.

[A cross-sectional study on the treatment goals of blood pressure, serum lipids and blood glucose in elderly patients with coronary heart disease].

Zhu Y, Wang J, Bao Y, Qiao YX, Wu LZ, Li J, Li J, Hu DY.

Zhonghua Yi Xue Za Zhi. 2011 Jun 7;91(21):1479-85. Chinese.

PMID:
21914285
12.

Risk factors of diabetic retinopathy in type 2 diabetic patients.

Cai XL, Wang F, Ji LN.

Chin Med J (Engl). 2006 May 20;119(10):822-6.

PMID:
16732984
13.

Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.

Lepira FB, M'Buyamba-Kabangu JR, Kayembe KP, Nseka MN.

Cardiovasc J S Afr. 2005 Sep-Oct;16(5):249-55.

14.

Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.

Wang JS, Lin SD, Lee WJ, Su SL, Lee IT, Tu ST, Tseng YH, Lin SY, Sheu WH.

Clin Ther. 2011 Dec;33(12):1932-42. doi: 10.1016/j.clinthera.2011.10.014. Epub 2011 Nov 10.

PMID:
22078152
15.

Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.

Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Osada S, Koide H.

Diabetes Care. 2005 Nov;28(11):2728-32.

PMID:
16249547
16.

[Treatment of diabetic nephropathy by integrative medicine: a multi-center prospective cohort study].

Li Q, Zhang HM, Fei YT.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012 Mar;32(3):317-21. Chinese.

PMID:
22686074
17.
18.

Association between microalbuminuria and cardiovascular disease in type 2 diabetes mellitus of the Beijing Han nationality.

Guo L, Cheng Y, Wang X, Pan Q, Li H, Zhang L, Wang Y.

Acta Diabetol. 2012 Dec;49 Suppl 1:S65-71. doi: 10.1007/s00592-010-0205-5. Epub 2010 Jul 1.

PMID:
20593206
19.

[Change and significance of urinary smad3 in type 2 diabetic nephropathy].

Guo KF, Kou JX, Lu JX, Zhang L, Yu HY, Chen HB.

Zhonghua Yi Xue Za Zhi. 2013 Apr 9;93(14):1067-71. Chinese.

PMID:
23902838
20.

Familial factors in diabetic nephropathy: an offspring study.

Agius E, Attard G, Shakespeare L, Clark P, Vidya MA, Hattersley AT, Fava S.

Diabet Med. 2006 Mar;23(3):331-4.

PMID:
16492220

Supplemental Content

Support Center